Procedural Safety and Predictors of Acute Outcome of Intracoronary Administration of Progenitor Cells in 775 Consecutive Procedures Performed for Acute Myocardial Infarction or Chronic Heart Failure | Zendy

Salvatore De Rosa | Zendy; Florian Seeger | Zendy; Jörg Honold | Zendy; Ulrich FischerRasokat | Zendy; Ralf Lehmann | Zendy; Stephan Fichtlscherer | Zendy; Volker Schächinger | Zendy; Stefanie Dimmeler | Zendy; Andreas M. Zeiher | Zendy; Birgit Aßmus | Zendy

Open Access

Procedural Safety and Predictors of Acute Outcome of Intracoronary Administration of Progenitor Cells in 775 Consecutive Procedures Performed for Acute Myocardial Infarction or Chronic Heart Failure

Author(s) -

Salvatore De Rosa,

Florian Seeger,

Jörg Honold,

Ulrich FischerRasokat,

Ralf Lehmann,

Stephan Fichtlscherer,

Volker Schächinger,

Stefanie Dimmeler,

Andreas M. Zeiher,

Birgit Aßmus

Publication year - 2013

Publication title -

circulation cardiovascular interventions

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.621

H-Index - 95

eISSN - 1941-7632

pISSN - 1941-7640

DOI - 10.1161/circinterventions.112.971705

Subject(s) - myocardial infarction , medicine , heart failure , cardiology , progenitor cell , intensive care medicine , emergency medicine , stem cell , genetics , biology

Cell-based therapies are a promising option in patients with acute myocardial infarction or chronic heart failure (CHF). However, administration of cells requires intracoronary or intracardiac instrumentation, which is potentially associated with periprocedural risks. Therefore, we analyzed periprocedural complications and 30-day outcome in 775 consecutive procedures of intracoronary administration of progenitor cells using the stop-flow technique.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research